Drawing for BIOXIS PHARMACEUTICALS

USPTO serial 79265623

BIOXIS PHARMACEUTICALS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PINO, BRIAN
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BIOXIS PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and substances; dermatological products; pharmaceutical products for the treatment of acne, keratosis, seborrhea, psoriasis, signs and symptoms of photo-aging; products for the repair and healing of nerve endings; medical products for skin restoration and growth, namely, products injected in or under the skin, in or under mucous membranes, in or under adipose tissues for use as alternatives to a plastic surgery treatment and/or for filling, remodeling, increasing the volume of any part of the body and for skin regeneration; cartilage reconstruction product; disc hernia treatment product; vaccine vector productACTIVE—
010Surgical, medical and veterinary apparatus and instruments; syringes for injection of dermatological products; suture material; implant of any kind and for any use and in particular general surgery implants, visceral and parietal surgery implants, implants for reconstructive and aesthetic surgery, cardiovascular implants, dental implants, orthopedic implants; biocompatible materials for medical use including visco-supplementation substances, designed to fill wrinkles and increase volumeACTIVE—
042Scientific and medical research; design and development of pharmaceutical and therapeutic products; consultancy with respect to the development of implants and prostheses; medical and scientific research in the field of pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 18, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 30, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 30, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 13, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 27, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 30, 2020MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 30, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 5, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 14, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 6, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 30, 2019DOCKASSIGNED TO EXAMINER—
Aug 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance